Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | PKLR | P30613 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.45 |
| ▸ | FNTA | P49354 | 1/20 | 0.44 |
| ▸ | FNTB | P49356 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5149287 | 0.87 | MMP9 (0.44) | L3MBTL1 | |
| SCHEMBL1168298 | 0.85 | MMP2 (0.46) | CA2 | |
| SCHEMBL3863364 | 0.84 | MMP9 (0.57) | SMN1; SMN2L3MBTL1KEAP1 | |
| SCHEMBL5706285 | 0.84 | MMP9 (0.57) | SMN1; SMN2L3MBTL1KEAP1 | |
| SCHEMBL9670221 | 0.84 | NSD2 (0.45) | ALDH1A1 | |
| SCHEMBL7438340 | 0.83 | LMNA (0.61) | LMNAPKMPKLRSMN1; SMN2GAA | |
| SCHEMBL3465132 | 0.83 | MMP9 (0.60) | L3MBTL1CA2CA1 | |
| SCHEMBL4137790 | 0.83 | MMP9 (0.60) | L3MBTL1CA2CA1 | |
| SCHEMBL6266412 | 0.83 | PKLR (0.50) | PKLR | |
| SCHEMBL319322 | 0.82 | MMP9 (0.61) | CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240050572-A1 | Polysorbate Mixtures Having Modified Fatty Acid Ester Distribution | GENENTECH, INC. (US) | 2024-02-15 | — | — | US | disclosed |
| US-11833206-B2 | Polysorbate mixtures having modified fatty acid ester distribution | GENENTECH, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| EP-4217003-A1 | POLYSORBATE MIXTURES HAVING MODIFIED FATTY ACID ESTER DISTRIBUTION | Genentech, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| CN-116528906-A | Polysorbate blends with modified fatty acid ester distribution | 基因泰克公司 | 2023-08-01 | — | — | CN | disclosed |
| US-20220111054-A1 | POLYSORBATE MIXTURES HAVING MODIFIED FATTY ACID ESTER DISTRIBUTION | GENENTECH, INC. (US) | 2022-04-14 | — | — | US | disclosed |
| WO-2022066858-A1 | POLYSORBATE MIXTURES HAVING MODIFIED FATTY ACID ESTER DISTRIBUTION | GENENTECH, INC. (US) | 2022-03-31 | — | — | WO | disclosed |
| US-6746663-B2 | PHOTODYNAMIC DIAGNOSIS AND/OR TREATMENT FOR ANIMALS, | PHOTOCHEMICAL CO., LTD. (JP) | 2004-06-08 | — | — | US | disclosed |
| US-20030017112-A1 | Used for photodynamic diagnosis and/or treatment for animals | PHOTOCHEMICAL CO., LTD. (JP) | 2003-01-23 | — | — | US | disclosed |
| EP-1148058-A1 | PORPHYRIN COMPOUND | Photochemical Co., Ltd. (JP) | 2001-10-24 | — | — | EP | disclosed |
| US-5210029-A | Cultivating Escherichia Coli with Iron and Magnesium Sources | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-05-11 | — | — | US | disclosed |
| EP-0200417-B1 | PRODUCTION OF PROTEIN | Takeda Chemical Industries, Ltd. (JP) | 1992-10-21 | — | — | EP | disclosed |
| EP-0200417-A2 | Production of protein | Takeda Chemical Industries, Ltd. (JP) | 1986-11-05 | — | — | EP | disclosed |
| US-4540548-A | Method of detecting fluorescent materials and apparatus for their detection | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1985-09-10 | — | — | US | disclosed |
| US-4419452-A | Method of detecting fluorescent materials and apparatus for their detection | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1983-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030017112-A1 | Used for photodynamic diagnosis and/or treatment for animals | PPOX, PPIF, VHL | LMNA 3885/4885PKM 794/4885PKLR 795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.